May Lab
Focusing on improving outcomes for patients with digestive diseases
Dr. May joined other national health experts at White House Cancer Moonshot Colorectal Cancer Forum
She was an invited member for a panel at this event to discuss equitable access to high-quality cancer care and the need to invest in research to enable us to determine how to deliver the best care and perform effective outreach to underserved communities.
$3M NIH grant awarded
Drs. Fola May and Beth Glenn were awarded a $3 million grant from the National Institutes of Health to improve follow-up care for colorectal cancer screening in underserved populations.
The May Lab strongly represented at DDW 2024
Digestive Disease Week (DDW) was held May 18-21 in Washington, DC.
Latest News
A New York Times article asked leading authorities for the truth about probiotics, elimination diets, leaky gut and more. Folasade P. May, MD, PhD, MPhil, discussed bowel movement consistency, and Kate Mintz, MSN, RDN, discussed diagnosing food sensitivities.
New study hopes to explain why more black women are getting cancer
"We know that even though black women are likely to get screened for breast cancer ... the quality of the screening and the care that they get, the timeliness of the care, is not [at] a point where it needs to be." -- Folasade P. May, MD, PhD, MPhil, director of the Melvin and Bren Simon GI Quality Improvement Program and member of the UCLA Health Jonsson Comprehensive Cancer Center.
Balancing hope and reality: The promise and peril of blood-based colorectal cancer screening
Blood-based tests are important to expand options for patients and their physicians in colorectal cancer screening. But tests that both prevent and detect colorectal cancer early should continue to be the encouraged gold standard. After all, it’s better to prevent colorectal cancer before it occurs than catch it afterward, says Dr. Fola May.
$8M grant received to help address colorectal cancer disparities
Dr. May, selected as part of the Stand Up to Cancer Health Equity Dream Team, will help coordinate an innovative and comprehensive approach that will bring together leading researchers, patient advocates, community leaders, and clinicians to accomplish several goals, including improving colorectal cancer screening in medically underserved communities.